RT Journal Article SR Electronic T1 Emergence of two distinct SARS-CoV-2 Gamma variants and the rapid spread of P.1-like-II SARS-CoV-2 during the second wave of COVID-19 in Santa Catarina, Southern Brazil JF medRxiv FD Cold Spring Harbor Laboratory Press SP 2022.01.13.22268697 DO 10.1101/2022.01.13.22268697 A1 Dayane A. Padilha A1 Vilmar Benetti-Filho A1 Renato S. Moreira A1 Tatiany A. T. Soratto A1 Guilherme A. Maia A1 Ana P. Christoff A1 Fernando H. Barazzetti A1 Marcos A. Schörner A1 Fernanda L. Ferrari A1 Carolina L. Martins A1 Eric K. Kawagoe A1 Julia K. Wachter A1 Paula Sacchet A1 Antuani R. Baptistella A1 Aline D. Schlindwein A1 Bruna K. Coelho A1 Sandra B. Fernandes A1 Darcita B. Rovaris A1 Marlei P. D. Anjos A1 Fernanda R. Melo A1 Bianca Bittencourt A1 Sthefani Cunha A1 Karine L. Meneghetti A1 Nestor Wendt A1 Tamela Z. Madaloz A1 Marcus V. D. Rodrigues A1 Doris S. M. Souza A1 Milene H. Moraes A1 Rodrigo P. Baptista A1 Guilherme Toledo-Silva A1 Guilherme R. Maciel A1 Edmundo C. Grisard A1 Patrícia H. Stoco A1 Luiz F. V. Oliveira A1 Maria L. Bazzo A1 Gislaine Fongaro A1 Glauber Wagner YR 2022 UL http://medrxiv.org/content/early/2022/02/11/2022.01.13.22268697.abstract AB The Western mesoregion, the State of Santa Catarina (SC), Southern Brazil, was heavily affected as a whole by the COVID-19 pandemic in early 2021. This study aimed to evaluate the dynamics of the SARS-CoV-2 virus spreading patterns in the SC state through March 2020 to April 2021 using genomic surveillance. During this period, 23 distinct variants, including Beta and Gamma, among which, the Gamma and related lineages were predominant in the second pandemic wave within SC. A regionalization of P.1-like-II in the Western-SC region was observed, concomitant to the increase in cases, mortality, and case fatality rate (CFR) index. This is the first evidence of the regionalization of the SARS-CoV-2 in SC transmission and highlights the importance of tracking variants, dispersion, and impact of SARS-CoV-2 on the public health systems.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by Santa Catarina Research Foundation (Fundacao de Amparo a Pesquisa e Inovacao of Santa Catarina, FAPESC, Santa Catarina, Brazil) (grant number COV2020051000065), CAPES (Coordination for the Improvement of Higher Education Personnel, Brazil), CNPq (National Council for Scientific and Technological Development, Brazil) and UFSC (Federal University of Santa Catarina). DAP, VBF, TATP, GAM, CLM, EKK and TZM were recipients of FAPESC, CAPES or CNPq scholarships.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Federal University of Santa Catarina Ethics Committee (CAAE: 31521920.8.0000.0121)I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present work are contained in the manuscript